文献速递眼底病与葡萄膜炎

无渗出性年龄相关性黄斑变性眼经扫频源光学相干断层扫描血管成像检测到的亚临床新生血管的两年渗出风险

Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.
PubMed 文献 · Am J Ophthalmol · 2019-06-21

前瞻性队列研究纳入227只无渗出性年龄相关性黄斑变性眼,用扫频源光学相干断层扫描血管成像检测亚临床黄斑新生血管,随访2年。亚临床新生血管眼发生渗出的相对风险为无亚临床新生血管眼的13.6倍(95%CI 4.9-37.7,P<.001),病变大小本身与渗出风险无显著关联(P=.91)。作者建议对无症状渗出的亚临床新生血管眼密切随访而不治疗。

要点

  • 无渗出性年龄相关性黄斑变性眼中,首次成像时亚临床黄斑新生血管患病率为13.2%(30/227)。
  • 检测到亚临床新生血管后,渗出发生率为34.5%,渗出相对风险为无亚临床新生血管眼的13.6倍(95%CI 4.9-37.7,P<.001)。
  • 病变大小本身与渗出风险无显著关联(P=.91)。

核心结论

  • 至24个月时,经扫频源光学相干断层扫描血管成像检测到亚临床黄斑新生血管的眼发生渗出的风险为无亚临床新生血管眼的13.6倍(95%CI 4.9-37.7,P<.001)。
  • 作者建议对无有症状渗出的亚临床黄斑新生血管眼密切随访而不治疗。

研究设计与样本

  • 前瞻性队列研究,纳入2014年8月至2018年3月期间227例患者(154只中等期和73只晚期年龄相关性黄斑变性眼),使用3×3毫米和6×6毫米扫频源光学相干断层扫描血管成像扫描模式,通过外层视网膜至毛细血管层en face slab检测黄斑新生血管,评估2年内的患病率、发病率、渗出累积风险及新生血管病变大小与渗出风险的关联。

主要发现

  • 227只眼中,30只眼(13.2%)首次成像时有亚临床黄斑新生血管,12只眼(8.9%)在随访期间发生亚临床黄斑新生血管。
  • 在191只随访超过1次的眼睛中,19只眼发生渗出,其中14只眼有预先存在的亚临床黄斑新生血管。
  • 从首次检测到任何亚临床黄斑新生血管时起,渗出发生率为34.5%。
  • 检测到亚临床黄斑新生血管后,渗出的相对风险为无亚临床黄斑新生血管眼的13.6倍(95%CI 4.9-37.7,P<.001)。
  • 仅基于病变大小无显著渗出风险(P=.91)。

关键数值与推荐

  • 亚临床黄斑新生血管在首次成像时的患病率为13.2%(30/227眼)。
  • 随访期间亚临床黄斑新生血管发病率为8.9%(12/227眼)。
  • 检测到亚临床黄斑新生血管后渗出发生率为34.5%。
  • 亚临床黄斑新生血管眼渗出相对风险为13.6(95%CI 4.9-37.7,P<.001)。
  • 病变大小与渗出风险无显著关联(P=.91)。

临床怎么用

  • 作者建议对无有症状渗出的亚临床黄斑新生血管眼密切随访而不治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Swept source optical coherence tomography angiography (SS-OCTA) was used to study the prevalence, incidence, and natural history of subclinical macular neovascularization (MNV) in eyes with unilateral nonexudative age-related macular degeneration. DESIGN: Prospective cohort study. METHODS: Patients were imaged using 3- × 3-mm and 6- × 6-mm SS-OCTA scan patterns. MNV was detected using the outer retina to choriocapillaris en face slab. Prevalence and incidence of subclinical MNV, Kaplan-Meier cumulative estimates for the overall risk of exudation, and the association between neovascular lesion size and the risk of exudation were assessed through 2 years. RESULTS: From August 2014 through March 2018, 227 patients (154 intermediate and 73 late age-related macular degeneration eyes) underwent SS-OCTA imaging. Thirty eyes (13.2%) had subclinical MNV at first imaging and 12 eyes (8.9%) developed subclinical MNV during follow-up. Of the 191 eyes with >1 visit, 19 developed exudation. Fourteen of these eyes had pre-existing subclinical MNV. The incidence of exudation from the time of first detection of any subclinical MNV was 34.5%. The relative risk of exudation after detection of subclinical MNV was 13.6 times greater (95% confidence interval 4.9-37.7) than in the absence of subclinical MNV (P < .001). There was no significant risk of exudation based on lesion size alone (P = .91). CONCLUSIONS: By 24 months, the risk of exudation was 13.6 times greater for eyes with subclinical MNV detected by SS-OCTA compared with eyes without subclinical MNV. For eyes with subclinical MNV in the absence of symptomatic exudation, we recommend close follow-up without treatment.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yang J, Zhang Q, Motulsky EH, et al. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography. Am J Ophthalmol. 2019. PMID: 31229464. doi:10.1016/j.ajo.2019.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。